CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear
Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CLL combo aims for Long-Term remission without lifelong pills
Disease control Not yet recruitingThis phase II trial tests a new drug called pirtobrutinib combined with a short course of chemotherapy in 82 fit patients with untreated CLL. The goal is to achieve deep remission with undetectable cancer cells in the blood at 24 months. The treatment lasts only 15 months, aiming…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for Hard-to-Treat blood cancers? early trial of MS-553 begins
Disease control Not yet recruitingThis early-phase trial is testing an experimental drug called MS-553 in 12 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to treatment. The main goal is to check the drug's safety and find the right dose…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC